2024-03-29T17:27:15Z
http://www.transresurology.com/?_action=export&rf=summon&issue=16076
Translational Research in Urology
Trans Res Urol
2020
2
2
Leydig Cell Tumor in Children: a Case Report and Literature Review
Khashayar
Atqiaee
Arash
Mohammadi Tofigh
Shahab
Salehpour
Alireza
Mirshemirani
IntroductionLeydig cell tumors (LCTs) comprise 1 to 3 percent of testicular cancers in children, one of the most common symptoms in prepubertal patients is painless testicular swelling with or without a sign of precocious puberty. Other symptoms depend on age and the type of tumor. The tumor is usually asymptomatic if secrets androgens can cause precocious puberty in young children. If the tumor secretes estrogens, it can rarely cause gynecomastia in young boys.Case presentationHere we are reporting pure LCTs in a ten-year-old boy presented with gynecomastia. His height and weight were in the normal range. Differential diagnosis of large cell calcifying Sertoli cell or Leydig cell tumor, teratomas and revealed the normal size and echogenicity of both epididymis confirmed the Leydig cell tumor.ConclusionsDue to the highly variable clinical presentation of tumors, especially in children, the importance of maintaining fertility in this group, and the increased incidence of malignancy, especially in adolescence, early detection and timely treatment are crucial.
Gynecomastia
precocious puberty
Testicular tumor
2020
05
10
32
36
http://www.transresurology.com/article_118043_c10becc69cf2a3df35ef1f1e2997a862.pdf
Translational Research in Urology
Trans Res Urol
2020
2
2
Antegrade Urethral Approach for Urethral Stricture in Patients with Previous Failed Retrograde Intervention
Sobhan
Alishah
Feraidoon
Khayyamfar
Seyed kazem
Foroutan
IntroductionUrethral stricture has challenging difficulties in its treatment. Various treatment modalities had been used e.g.; urethral dilatation is one of the oldest methods. Severe bleeding and several false passages may end in failure, which may make retrograde access impossible. The purpose of this study was to describe safety in antegrade accessing followed by retrograde dilatation with am Platz renal dilator.MethodsA total number of 15 patients with difficult urethral stricture and failed retrograde approaches were entered into the study. Guidewire was passed through the cystostomy for proper retrograde accessing which was delivered through external urethral meatus followed by retrograde dilation. Patient parameters were analyzed, all patients had retrograde urethrography (RUG) pre-and post-operative, max flow rate (Qmax) on uroflowmetry (UF) in addition to post voiding residual urine (PVR). Patients were followed at 2, 6, and 12 months. The technique described was enabling us to get safe antegrade urethral access followed by stepwise retrograde am Platz renal dilation.ResultsThe mean age of patients was 39.2 ± 16.7 years. Preoperative uroflowmetry demonstrate Qmax 2ml/sec and ultrasonography showed PVR of 315ml ranging from 35 to1000ml. In post-operation uroflowmetry Qmax was raised to 19ml/sec (p-value<0.001), 18 ml/sec (p-value<0.001) and 15ml/sec (p-value<0.001) respectively. PVR values were 9ml with (p-value<0.001), 11ml (p-value<0.001) and 13ml (p-value<0.001) respectively. Operation time was 10 minutes for antegrade passage of a guidewire, followed by 25 minutes for retrograde dilatation. In patients who had was no cystostomy, an average of 32 minutes was required. Two patients had recurrence during a 12 months follow-up.ConclusionsThe antegrade approach is a safe applicable approach for the treatment of difficult urethral stricture, followed by retrograde stepwise dilatation. This technique can be tolerated well and cost-effective for patients in whom getting retrograde access was not possible and may avoid these patients to go under urethroplasty.
Antegrade
dilatation
Urethral stricture
Am Platz Dilators
Cystostomy
2020
04
01
37
44
http://www.transresurology.com/article_118874_f710daa8eb13e793fb4d78a9aa622b52.pdf
Translational Research in Urology
Trans Res Urol
2020
2
2
Cytotoxicity and Apoptotic Effect of Nisin as an Effective Bacteriocin on the Cancer Cells
Samira
Karimaei
Leonardo
Oliveira Reis
Different therapeutic approaches, comprising surgery, radiotherapy, chemotherapy are used for cancer treatment. There is an extreme need for novel anti-cancer agents with minimal toxicity for normal cells that are significantly growing. Nowadays, bacteriocins or antimicrobial peptides (AMPs) are considered tumor cell killers. In this regard, Nisin is one of the natural AMPs produced by Lactococcus lactis. Considering that Nisin could make apoptosis through inherent pathways and cause cancer cell death, it was suggested that at appropriate doses it might be efficient and safe for cancer treatment, room for future studies.
cancer
Nisin
cancer cells
Chemotherapy
2020
05
15
45
47
http://www.transresurology.com/article_118875_499e3013dacda9b1ca5a6e83af87492e.pdf
Translational Research in Urology
Trans Res Urol
2020
2
2
Measuring Stone Free Rate after Mini Percutaneous Nephrolithotomy: Radiography, Ultrasound, or CT scan?
Alimohammad
Fakhr Yasseri
Diana
Taheri
Stone-free rate (SFR) after treatment can be estimated by plain radiography and ultrasonography, or computed tomography (CT) scanning. Based on the guidelines, CT is the primary method for SFR estimation after PCNL (percutaneous nephrolithotomy) due to its high sensitivity and wide availability. However, there is an extreme need to minimize unnecessary radiation exposure in patients. The CT scanning is more indispensable in the minimally invasive PCNL (MPCNL) technique to detect small residual stone fragments. Finally, we believe that using CT scan in follow up of MPCNL patients, rather than plain radiography and ultrasonography, is more accurate to detect residual fragments and estimate SFR as one of the important outcomes of this operations.
Stone Free Rate
Percutaneous nephrolithotomy
nephrolithotomy
Paediatric Renal Stones
2020
04
01
48
50
http://www.transresurology.com/article_119265_232018ae77a058a6eee8f6fc7f9a740a.pdf
Translational Research in Urology
Trans Res Urol
2020
2
2
Biomarkers for Prostate Cancer Diagnosis from Genetic Perspectives
Fatemeh
Khatami
Seyed Mohammad Kazem
Aghamir
Arash
Salmaninejad
Sepideh
Shivarani
Mohammad Hatef
Khorrami
Prostate cancers (PC) are mainly diagnosed by screening prostate-specific antigen (PSA) quantity in the blood or a digital rectal exam (DRE). PC typically does not have symptoms contrary to advanced cancers that are diagnosed due to significant symptoms. Diagnosis of PC is established with the transrectal ultrasound (TRUS) guided biopsy. Estimation of the free PSA to total PSA (fPSA/tPSA) ratio and Multiparametric-magnetic resonance imaging (mp-MRI) can expand the diagnosis accuracy. Several molecular biomarkers have improved PC diagnosis like Confirm MDx, Prostate Core Mitomic Test (PCMT), TMPRSS2-ERG, The PTEN gene, ProMark, 4K score including, and Circulating Tumor Cells (CTCs). These molecular biomarkers are considered both genetic and epigenetic (DNA methylation) hallmarks of PC. We aim to present an overview of all molecular biomarkers of PC and their implication in improving the management of PC patients.
Prostate Cancer
Diagnosis
Biomarker
2020
05
20
51
58
http://www.transresurology.com/article_120189_95e558ce7e355fb44a09656d304b9616.pdf
Translational Research in Urology
Trans Res Urol
2020
2
2
Vaccine Production by Recognizing the Functional Mechanisms of COVID-19
Akram
Mirzaei
Diana
Taheri
Leonardo
Oliveira Reis
With the rapid worldwide spread of a new coronavirus with the scientific name SARS-CoV-2 at the beginning of 2020, attempts to produce a vaccine started in different countries. This study aimed to review the mechanisms and functions of the coronavirus protein as a basis for vaccine production. A rapid review of available studies is conducted. Related information was extracted and summarized, compared, and discussed with regards to the coronavirus mechanisms and acts as a pathogen, including apoptosis and autophagy. An overview of available information on coronavirus functional mechanisms was performed to aid researchers in the development and production of vaccines against it.
COVID-19 vaccine
Coronavirus
Apoptosis
Autophagy
2020
05
22
59
68
http://www.transresurology.com/article_120241_9fb7884854d8d38b12de2c97a7402851.pdf
Translational Research in Urology
Trans Res Urol
2020
2
2
Compound Nevus with Severe Dysplastic Feature in Mixed Germ Cell Tumor: A Case Report
Alimohammad
Fakhr Yasseri
Negar
Behtash
Mahboobe
Asadi
Mohammad Ghasem
Mohseni
IntroductionTesticular cancer is the most common tumor of the genital tract of 18-39 years-old men; its incidence is increasing in recent decades. However, the 10-year survival rate of testicular cancer is above 90%, which can result from radiation and chemotherapy used to treat patients. Testicular cancer patients are at risk for secondary malignancies; in this regard, the effects of radiation are brighter than chemotherapy. Recent studies reported melanoma and malignant skin changes as secondary malignancies in these people.Case presentationthis study introduces a 31-year-old patient with a mixed germ cell tumor and severe dysplastic changes in a compound nevus. Our patient had long-term exposure to sunlight and numerous skin nevi before diagnosing testicular cancer.Conclusions The findings do not support the relationship between the emergence of a nevus with severe dysplastic changes and testicular tumors.
Keywords: Testicular Tumor
compound nevus
germ cell
second malignancy
2020
06
15
69
73
http://www.transresurology.com/article_121001_884ba5803a9db4a6b881bc40a40932ec.pdf